Livio Moretti

Distribution Strategy (eBook, PDF)

The BESTX® Method for Sustainably Managing Networks and Channels

• Format: PDF

Produktbeschreibung

Explains how to create a future-proof win-win relation with the trade partners providing a proprietary methodology (named BESTX®)

Includes clear steps on how to define an effective and efficient commercial policy and implement value pricing strategies properly

Provides diverse and ready to use strategies within the methodology that allow the reader to enter in execution mode from day one

---

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Produktdetails

• Verlag: Springer International Publishing
• Seitenzahl: 216
• Erscheinungstermin: 2. November 2018
• Englisch
• ISBN-13: 9783319919591
• Artikelnr.: 54496934

Autorenporträt

Livio Moretti is currently Global Corporate Strategy Director for a major Pharmaceutical Company. For several years he has been implementing commercial excellence initiatives with top-tier management consultancies (McKinsey&Co, The Boston Consulting Group) for Fortune 100 multinationals around the Globe.

Graduated in Management Engineering at Politecnico di Milano, summa cum laude, and in Economics Engineering at Ecole Centrale Paris, he received an MBA degree from INSEAD Business School. At 35, after selling his first business, he co-founded a venture fund active in Real Estate, NPLs and Retail. He has been a guest speaker for international MBA programs on competitive strategy and author of several articles on commercial excellence.

Inhaltsangabe

Introduction to Distribution Strategy.- Phase 1 - Build the End-State Strategy.- Phase 2 - Evaluate Context: Transactional Analysis, Competition, Channels.- Phase 3 - Segment Channels and Partners.- Phase 4 - Commercial Terms Redesign. Phase 5 - Execute: Infrastructure and Tracking.- Common Pitfalls.- Business Intelligence.- Annex: Case Study - The Pharmaceutical Industry.- Final Remark.